Search

Search Results

Found 38 items.

Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

Gary E. Raskob

16-05-2024

Published: 16 May 2024

320

PDF: 153
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

Agnes Y.Y. Lee

29-02-2024

Published: 29 February 2024

1246

PDF: 209
Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo

24-10-2022

Published: 24 October 2022

445

PDF: 157
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

04-09-2024

Published: 4 September 2024

530

PDF: 114

SUPPLEMENTARY MATERIAL: 78
Cancer-associated ischemic stroke: current knowledge and future directions

Ronda Lun, Deborah M. Siegal

16-05-2024

Published: 16 May 2024

1036

PDF: 271
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan

17-10-2022

Published: 17 October 2022

2149

PDF: 217

Supplementary Files: 47
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

16-05-2024

Published: 16 May 2024

421

PDF: 180
New perspectives for prevention of the post-thrombotic syndrome

Paolo Prandoni

22-03-2022

Published: 22 March 2022

1280

PDF: 412
Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

14-12-2022

Published: 14 December 2022

657

PDF: 282
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

Ang Li, Emily Zhou

16-05-2024

Published: 16 May 2024

441

PDF: 166
Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

03-11-2022

Published: 3 November 2022

731

PDF: 238
Venous thromboembolism and mortality in patients with hematological malignancies

Kristen M. Sanfilippo, Tzu-Fei Wang

16-05-2024

Published: 16 May 2024

305

PDF: 121
Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia

Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga

28-06-2023

Published: 28 June 2023

424

PDF: 151
Stroke in women: anticoagulation in a complicated puzzle

Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona

26-08-2024

Published: 26 August 2024

924

PDF: 245
Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele

08-05-2024

Published: 8 May 2024

508

PDF: 203
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

Published: 22 March 2022

846

PDF: 302

APPENDIX: 58
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

22-04-2024

Published: 22 April 2024

256

PDF: 56
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

27-07-2022

Published: 27 July 2022

4098

PDF: 329

Supplementary Files: 97
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

Mehrie H. Patel, Alok A. Khorana

16-05-2024

Published: 16 May 2024

274

PDF: 150
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

16-05-2024

Published: 16 May 2024

495

PDF: 230
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

12-10-2023

Published: 12 October 2023

657

PDF: 181
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

23-05-2022

Published: 23 May 2022

4544

PDF: 233
Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

Ottavia Borghese, Claudio Vincenzoni

26-06-2024

Published: 26 June 2024

869

PDF: 206
The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects

Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati

22-03-2022

Published: 22 March 2022

1643

PDF: 228
Palestinian patients associations appeal on World Hemophilia Day

Sara Mellano

17-04-2024

Published: 17 April 2024

237

PDF: 61
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

09-03-2023

Published: 9 March 2023

520

PDF: 317
Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

Giovanni Tiscia, Elvira Grandone

13-09-2022

Published: 13 September 2022

2111

PDF: 221
Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition

Boris Shenkman, Ivan Budnik, Yulia Einav

16-02-2023

Published: 16 February 2023

1182

pdf: 174
Ankle brachial index for the diagnosis of asymptomatic lower extremity peripheral arterial disease

Francesco Cicconi

05-07-2024

Published: 5 July 2024

1017

PDF: 247
Location of metastasis and complications in patients with venous thromboembolism and cancer: systematic review

Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

16-05-2024

Published: 16 May 2024

294

PDF: 105
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Paolo Simioni, Vittorio Pengo, Paolo Prandoni

07-11-2022

Published: 7 November 2022

1787

PDF: 199
Welcome to the 12^th ICTHIC!

Guest Editors: Anna Falanga, Benjamin Brenner, Alok A. Khorana

16-05-2024

Published: 16 May 2024

1245

PDF: 161
Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta

15-04-2022

Published: 15 April 2022

519

PDF: 192

Supplementary Files: 57
Polycythemia vera and management of the thrombotic risk: an update

Massimo Franchini

20-12-2023

Published: 20 December 2023

1711

PDF: 223
Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

23-05-2022

Published: 23 May 2022

5080

PDF: 414

APPENDIX: 95
Influence of emicizumab on protein C-mediated clotting regulation

Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

25-10-2023

Published: 25 October 2023

1819

PDF: 185

Supplementary Material: 33
Antithrombotic therapy in idiopathic infertility

Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

03-10-2024

Published: 3 October 2024

1184

PDF: 235
Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCoV-19) vaccine: report of two cases

Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò

23-05-2022

Published: 23 May 2022

3575

PDF: 243

1 - 38 of 38 items

Mostcitedplugin was unvalidated product, Click here to support us

© PAGEPress 2008-2024 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy